ISIN | CH0113817123 |
---|---|
Valor Number | 11381712 |
Bloomberg Global ID | BBG0017T9CY3 |
Fund Name | Bellevue Biotech DT CHF |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 3,877.83 CHF | 02.10.2025 |
---|---|---|
Previous Price * | 3,846.46 CHF | 01.10.2025 |
52 Week High * | 3,907.85 CHF | 11.11.2024 |
52 Week Low * | 3,036.56 CHF | 10.04.2025 |
NAV * | 3,877.83 CHF | 02.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 20,681,174 | |
Unit/Share Assets *** | 4,105,959 | |
Trading Information SIX |
YTD Performance | +7.33% |
31.12.2024 - 02.10.2025
31.12.2024 02.10.2025 |
---|---|---|
1 month | +5.13% |
02.09.2025 - 02.10.2025
02.09.2025 02.10.2025 |
3 months | +17.91% |
02.07.2025 - 02.10.2025
02.07.2025 02.10.2025 |
6 months | +8.81% |
02.04.2025 - 02.10.2025
02.04.2025 02.10.2025 |
1 year | +7.46% |
02.10.2024 - 02.10.2025
02.10.2024 02.10.2025 |
2 years | +18.51% |
02.10.2023 - 02.10.2025
02.10.2023 02.10.2025 |
3 years | +6.25% |
03.10.2022 - 02.10.2025
03.10.2022 02.10.2025 |
5 years | +8.65% |
02.10.2020 - 02.10.2025
02.10.2020 02.10.2025 |
Equity Participation Rate in % | 83.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 16.6695 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 02.10.2025 |
Gilead Sciences Inc | 7.54% | |
---|---|---|
Amgen Inc | 7.05% | |
Regeneron Pharmaceuticals Inc | 6.88% | |
Vertex Pharmaceuticals Inc | 6.50% | |
Alnylam Pharmaceuticals Inc | 6.35% | |
AstraZeneca PLC ADR | 6.04% | |
Insmed Inc | 3.34% | |
argenx SE ADR | 2.61% | |
Ionis Pharmaceuticals Inc | 2.07% | |
Biogen Inc | 1.99% | |
Last data update | 31.08.2025 |
TER | 1.22% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |